These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 445413)
21. Successful heterotransplantation of human colon cancer cells to athymic animals is related to tumor cell differentiation and growth kinetics and to host natural killer cell activity. Drewinko B; Moskwa P; Lotzovà E; Trujillo JM Invasion Metastasis; 1986; 6(2):69-82. PubMed ID: 3700013 [TBL] [Abstract][Full Text] [Related]
22. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon. Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194 [TBL] [Abstract][Full Text] [Related]
23. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates. Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305 [TBL] [Abstract][Full Text] [Related]
24. Localization of human GW-39 tumors in hamsters by radiolabeled heterospecific antibody to carcinoembryonic antigen. Primus FJ; Wang RH; Goldenberg DM; Hansen HJ Cancer Res; 1973 Nov; 33(11):2977-82. PubMed ID: 4800397 [No Abstract] [Full Text] [Related]
26. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model. Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050 [TBL] [Abstract][Full Text] [Related]
27. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft. Nelson H; Ramsey PS; Kerr LA; McKean DJ; Donohue JH J Immunol; 1990 Nov; 145(10):3507-15. PubMed ID: 1700013 [TBL] [Abstract][Full Text] [Related]
28. Use of second antibody in radioimmunotherapy. Begent RH; Bagshawe KD; Pedley RB; Searle F; Ledermann JA; Green AJ; Keep PA; Chester KA; Glaser MG; Dale RG NCI Monogr; 1987; (3):59-61. PubMed ID: 3493442 [TBL] [Abstract][Full Text] [Related]
29. Radioimmunotherapy with 153Sm-CEA monoclonal antibody in nude mice bearing human colon carcinoma: an experimental study. Li GP; Zhang H; Zhu CM Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):1-5. PubMed ID: 12527502 [TBL] [Abstract][Full Text] [Related]
30. Neoplastic growth of nude mouse tissue adjacent to xenografted human colonic carcinomas. Staab HJ; Heilbronner H; Schrader M; Anderer FA Z Versuchstierkd; 1983; 25(3):121-4. PubMed ID: 6613370 [No Abstract] [Full Text] [Related]
31. Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen. Sharkey RM; Kaltovich FA; Shih LB; Fand I; Govelitz G; Goldenberg DM Cancer Res; 1988 Jun; 48(11):3270-5. PubMed ID: 3365705 [TBL] [Abstract][Full Text] [Related]
33. Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody. Gautherot E; Kraeber-Bodéré F; Daniel L; Fiche M; Rouvier E; Saï-Maurel C; Thedrez P; Chatal JF; Barbet J Clin Cancer Res; 1999 Oct; 5(10 Suppl):3177s-3182s. PubMed ID: 10541361 [TBL] [Abstract][Full Text] [Related]
34. Carcinoembryonic antigen from human malignant melanoma cells. II. Grafting of the cells in the hamster cheek pouch. Hakim AA Ann Immunol (Paris); 1983; 134D(3):333-47. PubMed ID: 6687105 [TBL] [Abstract][Full Text] [Related]
35. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen. Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980 [TBL] [Abstract][Full Text] [Related]
36. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen. Fogler WE; Klinger MR; Abraham KG; Gottlinger HG; Riethmuller G; Daddona PE Cancer Res; 1988 Nov; 48(22):6303-8. PubMed ID: 2460221 [TBL] [Abstract][Full Text] [Related]
37. Circulating antibodies in rats bearing grafted colon carcinoma. Martin F; Martin M; Lagneau A; Bordes M; Knobel S Cancer Res; 1976 Sep; 36(9 pt.1):3039-42. PubMed ID: 61808 [TBL] [Abstract][Full Text] [Related]
38. Further biologic characteristics of a human carcinoembryonic antigen-producing colon carcinoma cell line. Drewinko B; Yang LY; Barlogie B; Romsdahl M; Meistrich M; Malahy MA; Giovanella B J Natl Cancer Inst; 1978 Jul; 61(1):75-83. PubMed ID: 276641 [No Abstract] [Full Text] [Related]
39. Prolonged localisation of a monoclonal antibody against CEA in a human colon tumour xenograft. Harwood PJ; Pedley RB; Boden J; Rawlins G; Pentycross CR; Rogers GT; Bagshawe KD Br J Cancer; 1985 Nov; 52(5):797-9. PubMed ID: 2998427 [No Abstract] [Full Text] [Related]
40. Monoclonal anticolon carcinoma antibodies in complement-dependent cytotoxicity. Herlyn DM; Koprowski H Int J Cancer; 1981 Jun; 27(6):769-74. PubMed ID: 7287228 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]